期刊文献+

低分子肝素超早期干预对DIC发生率的影响 被引量:1

Discuss the effect on the incidence of DIC with ultra-early intervention of LMWH
下载PDF
导出
摘要 目的研究对有DIC(disseminated intravascular coagulation,弥散性血管内凝血)高发因素的重症患者超早期应用低分子肝素(Low-Molecular-Weight Heparins Calcium Injection,LMWH)能否减少DIC的发生率。方法选择有DIC高发因素的重症患者46例随机分为2组,对照组按相应疾病诊疗常规治疗,LMWH超早期干预组在对照组方法治疗的基础上,在出凝血机制无明显障碍的前提下,入院即给予低分子肝素皮下注射2次/日。观察两组患者10天内DIC发生情况的差异。结果 LMWH超早期干预组发生DIC 1例(4.4%),对照组6例(26.1%)。对照组DIC发生率明显高于LMWH组,组间差异有显著性(P<0.05)。结论对有DIC高发因素的重症患者超早期应用低分子肝素治疗,能有效减少DIC的发生率,提高重症患者的存活率。 Objective To research the ultra-early intervention of LMWH (Low Molecular Weight Heparins Calcium Injection) in the severe case with high risk factors of cause DIC (disseminated intravascular coagulation) whether reduce the incidence of DIC. Methods 46 cases of patients with high risk factors of DIC were included and randomly divided into 2 groups. The control group was abided to the corresponding disease clinic routine treatment. Under the premise of no disorders of blood coagulation mechanism and based on the treatment of control group, give subcutaneous injection of LMWH to the ultra-early intervention group of patients 2 times per day. Observe the deference of the incidence cases of DIC between two groups of patients within 10 days. The results are analyzed by test. Results DIC occurred in 1 cases in the ultra-early intervention group and 6 cases in the control group. The incidence of DIC is 4.4% in the ultra-early in- tervention group and 26.1% in the control group. In control group the incidence of DIC was higher than that of LMWH group. In two groups of patients with the incidence of DIC had significant difference (P〈0. 05). Conclusion The Ultra early intervention of LMWH in the severe case with high risk factors of DIC can effectively reduce the incidence of DIC and improve the survival rate of severe patients.
出处 《西部医学》 2013年第5期755-756,共2页 Medical Journal of West China
关键词 弥散性血管内凝血 ICU 低分子肝素 Disseminated intravascular coagulation ICU Low-Molecular Weight Heparina Calcium Injection
  • 相关文献

参考文献8

二级参考文献53

  • 1中华医学会血液学学会第七届全国血栓与止血学术会议(1999年10月 长沙)专题讨论[J].血栓与止血学,1999,6(3):137-144. 被引量:2
  • 2姚斌,徐大庆.血浆D-二聚体对弥散性血管内凝血患者的检测及意义[J].辽宁医学杂志,2006,20(1):11-12. 被引量:21
  • 3林洪远.从KyberSept和OPTIMIST研究失败看肝素治疗脓毒症的潜力[J].中国危重病急救医学,2007,19(3):134-137. 被引量:27
  • 4Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign :internatianal guidelines for management of severe sepsis and septic shock[J]. Crit Care Med,2008,36(4) :1394 - 1396.
  • 5Aoki N, Matsuda T,Saito H, et al. A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation [ J ]. Int J Hematol,2002 ,75 ( 5 ) :540 - 547.
  • 6Watanabe R, Wada H, Miara Y, et al. Plasma levels of total plasminogen activator inhibitor - 1 (PAl - 1 ) and tPA/PAI - 1 complex in patients with disseminated intravascular coagulation and thrombotic throm- bocytopenic purpura [J]. Clin Apll Thromb Hemost, 2001; 7 (3): 229.
  • 7Bick RL: Disseminated intravascular coagulation. Current concepts of etiology, pathophysiology, diagnosis, and treatment [J]. Hematol Oncol Clin N Am, 2003; 17: 149.
  • 8Levi M, de Jonge E, Meijers J: The diagnosis of disseminated intravascular coagulation [J]. Blood Rev, 2002; 16: 217.
  • 9Marranen EF: Disseminated intravascular coagulation (DIC) [J]. Clin Lab Sci, 2000; 13: 239.
  • 10Dhainaut, JF, Yan, SB, Joyce, DE, et al. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation [ J]. J Thromb Haemost, 2004; 2: 1924.

共引文献18

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部